Literature DB >> 26550085

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience.

Yusuke Kondo1, Markus Linhart1, René P Andrié1, Joerg O Schwab1.   

Abstract

BACKGROUND: The effectiveness of the wearable cardioverter defibrillator (WCD) therapy in early post-myocardial infarction (MI) patients remains uncertain.
METHODS: We analyzed the characteristics and outcomes of patients who received a WCD in the early post-MI phase.
RESULTS: Twenty-four patients were followed-up for 8 months (range, 4-16 months). Two patients (8.3%) received appropriate shocks. Left ventricular ejection fraction improved after the WCD therapy (P<0.01). Fourteen patients (58%) received an implantable cardioverter defibrillator at the end of the follow-up period.
CONCLUSION: Early post-MI patients at high risk of sudden cardiac death may benefit from WCD therapy.

Entities:  

Keywords:  Acute myocardial infarction; Implantable cardioverter defibrillator; Sudden cardiac death; Wearable cardioverter defibrillator

Year:  2015        PMID: 26550085      PMCID: PMC4600887          DOI: 10.1016/j.joa.2015.03.007

Source DB:  PubMed          Journal:  J Arrhythm        ISSN: 1880-4276


  11 in total

1.  Usefulness of the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death.

Authors:  Shingo Sasaki; Hirofumi Tomita; Shuji Shibutani; Kei Izumiyama; Takumi Higuma; Taihei Itoh; Kenichi Sasaki; Daisuke Horiuchi; Masaomi Kimura; Ken Okumura
Journal:  Circ J       Date:  2014-10-31       Impact factor: 2.993

2.  How should we use the wearable cardioverter-defibrillator in Japan?

Authors:  Akihiko Shimizu
Journal:  Circ J       Date:  2014-11-11       Impact factor: 2.993

3.  Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.

Authors:  Mina K Chung; Steven J Szymkiewicz; Mingyuan Shao; Edwin Zishiri; Mark J Niebauer; Bruce D Lindsay; Patrick J Tchou
Journal:  J Am Coll Cardiol       Date:  2010-07-13       Impact factor: 24.094

4.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney
Journal:  Circulation       Date:  2012-12-19       Impact factor: 29.690

Review 5.  Wearable cardioverter-defibrillators.

Authors:  Arnon Adler; Amir Halkin; Sami Viskin
Journal:  Circulation       Date:  2013-02-19       Impact factor: 29.690

6.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

7.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

8.  Defibrillator implantation early after myocardial infarction.

Authors:  Gerhard Steinbeck; Dietrich Andresen; Karlheinz Seidl; Johannes Brachmann; Ellen Hoffmann; Dariusz Wojciechowski; Zdzisława Kornacewicz-Jach; Beata Sredniawa; Géza Lupkovics; Franz Hofgärtner; Andrzej Lubinski; Mårten Rosenqvist; Alphonsus Habets; Karl Wegscheider; Jochen Senges
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

9.  Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

Authors:  Andrew E Epstein; William T Abraham; Nicole R Bianco; Karl B Kern; Michael Mirro; Sunil V Rao; Edward K Rhee; Scott D Solomon; Steven J Szymkiewicz
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

Review 10.  Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.

Authors:  Helmut U Klein; Ilan Goldenberg; Arthur J Moss
Journal:  Eur Heart J       Date:  2013-05-31       Impact factor: 29.983

View more
  8 in total

1.  Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Systematic Review and Meta-Analysis.

Authors:  Ahmad Masri; Ahmed M Altibi; Sebhat Erqou; Mohammad A Zmaili; Ala Saleh; Raed Al-Adham; Karam Ayoub; Moaaz Baghal; Laith Alkukhun; Amr F Barakat; Sandeep Jain; Samir Saba; Evan Adelstein
Journal:  JACC Clin Electrophysiol       Date:  2019-01-30

Review 2.  [Wearable defibrillator : Current evidence].

Authors:  David Duncker; Christian Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-10-24

Review 3.  New horizon for infection prevention technology and implantable device.

Authors:  Yusuke Kondo; Marehiko Ueda; Yoshio Kobayashi; Joerg O Schwab
Journal:  J Arrhythm       Date:  2016-03-19

4.  Critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study".

Authors:  Johannes Sperzel; Ingo Staudacher; Olaf Goeing; Martin Stockburger; Thorsten Meyer; Ana Sofia Oliveira Gonçalves; Hanna Sydow; Tonio Schoenfelder; Volker Eric Amelung
Journal:  Med Devices (Auckl)       Date:  2018-06-08

5.  Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study.

Authors:  Sabine Ettinger; Michal Stanak; Piotr Szymański; Claudia Wild; Romana Tandara Haček; Darija Erčević; Renata Grenković; Mirjana Huić
Journal:  Med Devices (Auckl)       Date:  2017-11-14

6.  Extended Use of the Wearable Cardioverter-Defibrillator: Which Patients Are Most Likely to Benefit?

Authors:  Boldizsar Kovacs; Sven Reek; Nazmi Krasniqi; Urs Eriksson; Firat Duru
Journal:  Cardiol Res Pract       Date:  2018-11-29       Impact factor: 1.866

7.  Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis.

Authors:  Elaine Nguyen; Erin R Weeda; Christine G Kohn; Benjamin A D'Souza; Andrea M Russo; Stacey Noreika; Craig I Coleman
Journal:  J Innov Card Rhythm Manag       Date:  2018-05-15

Review 8.  Role of the Wearable Defibrillator in Newly Diagnosed Heart Failure.

Authors:  David Duncker; Christian Veltmann
Journal:  Curr Heart Fail Rep       Date:  2018-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.